Acorda Therapeutics Inc. (ACOR) stock plunged during pre-market. Here’s what you should know.
Acorda Therapeutics Inc. (ACOR) stock rose by 24.15% at the last close whereas the ACOR stock price fell by 9.30% in the pre-market trading session. Acorda Therapeutics develops treatments to help individuals with neurological diseases regain function and enhance their lives. INBRIJA has been authorized to treat OFF episodes in individuals with Parkinson’s disease who […]
Here’s how in the early morning session, the stock of Acorda Therapeutics, Inc. (ACOR) peaked
Acorda Therapeutics, Inc. (Nasdaq: ACOR) shares skyrocketed 468.03% to 3.92 in the pre-market session Monday, January 4, 2021, after the Company recently revealed that the previously disclosed 1-for-6 reverse stock split of its outstanding and accepted common stock shares had been completed. At 4:01 p.m., the reverse stock break took place. Eastern Time today, and […]
